Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck To Support Quebec Venture Fund

by Michael McCoy
April 2, 2012 | A version of this story appeared in Volume 90, Issue 14

Merck & Co. is investing $35 million in a new investment fund, the Merck Lumira Biosciences Fund, that’s intended to support early life sciences innovation in Quebec. Other investors in the fund, which hopes to raise $50 million in all, include Lumira Capital and Teralys Capital. Merck’s contribution is part of the $100 million it promised in 2010 to invest in Quebec life sciences R&D when it announced its decision to close the Merck Frosst Centre for Therapeutic Research in Montreal.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.